New technology paves the way for individualised menopause treatment plans
A UK start-up has developed an easy to use, accurate and reliable diagnostic technological test that could transform the way the menopause is diagnosed, monitored and managed.
Located at the Science and Technology Facilities Council (STFC)’s Daresbury Laboratory, at Sci-Tech Daresbury, Agile Life Sciences has developed an at-home urine sample collection test, which can identify where a woman is during various stages of her menopausal journey.
The test is more accurate and reliable than any current menopause test available and paves the way for individualised treatment plans for women, that can be monitored regularly to ensure that an optimal treatment pathway is identified.
From the urine sample provided, Agile uses state-of-the-art next generation sequencing to identify the ratio and abundance of each individual bacteria within the vagina, providing more accurate and reliable information relating to their individual ‘vaginome’.
An individualised treatment pathway for each woman can then be initiated, and the success of each treatment plan can be monitored regularly enabling the clinician to achieve optimum wellness.
Dr Jan Rogers, joint CEO and co-founder of Agile Life Sciences, said: “There is a clear need for a simple, accurate and affordable solution that will provide women and clinicians with the essential information about their vaginal health enabling them to refocus their treatment pathway from illness to wellness.
“Better ‘bespoke’ menopause management will enable women to take control and live the life they want.
“I am really looking forward to the next exciting stage for our journey, as we invite women to take part in our first pilot programme.”
Agile Life Science is now collaborating with expert menopause clinicians and clinics to initiate a pilot phase that launches in the UK this month.
